Cargando…
SLMP53-1 Inhibits Tumor Cell Growth through Regulation of Glucose Metabolism and Angiogenesis in a P53-Dependent Manner
The Warburg effect is an emerging hallmark of cancer, which has the tumor suppressor p53 as its major regulator. Herein, we unveiled that p53 activation by (S)-tryptophanol-derived oxazoloisoindolinone (SLMP53-1) mediated the reprograming of glucose metabolism in cancer cells and xenograft human tum...
Autores principales: | Ramos, Helena, Calheiros, Juliana, Almeida, Joana, Barcherini, Valentina, Santos, Sónia, Carvalho, Alexandra T. P., Santos, Maria M.M., Saraiva, Lucília |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013701/ https://www.ncbi.nlm.nih.gov/pubmed/31963392 http://dx.doi.org/10.3390/ijms21020596 |
Ejemplares similares
-
SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma
por: Gomes, Sara, et al.
Publicado: (2019) -
Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule
por: Soares, Joana, et al.
Publicado: (2015) -
Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance
por: Loureiro, Joana B., et al.
Publicado: (2021) -
Metabolism-Guided Optimization of Tryptophanol-Derived Isoindolinone p53 Activators
por: Barcherini, Valentina, et al.
Publicado: (2023) -
DIMP53‐1: a novel small‐molecule dual inhibitor of p53–MDM2/X interactions with multifunctional p53‐dependent anticancer properties
por: Soares, Joana, et al.
Publicado: (2017)